(Updated - June 4, 2021 6:04 AM EDT)Oppenheimer analyst Leland Gershell initiates coverage on Windtree Therapeutics (NASDAQ: WINT) at Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE